Author

Jose Luis Labandeira

Institutions: Universidade de Santiago de Compostela, Biomedical Research Networking Center on Neurodegenerative Diseases, Center for Research in Molecular Medicine and Chronic Diseases, Instituto de Investigación Sanitaria de Santiago

Observed institutions: Universidade de Santiago de Compostela, Biomedical Research Networking Center on Neurodegenerative Diseases, Center for Research in Molecular Medicine and Chronic Diseases, Instituto de Investigación Sanitaria de Santiago, Universitat de Barcelona

OpenAlex ID: A5087137825

Plasma Aβ40, Aβ42, Aβ42/40 ratio, tau, p ‐tau181, p ‐tau217 and NfL biomarkers to discriminate the prodromal stage of dementia along the continuum of cognitive impairment: Sex differences in the CompAS study

2025 · Ana I. Rodríguez‐Pérez, Juan J. Ansede‐Bermejo, et al. · Alzheimer s & Dementia

[p4–455]: Neuroprotective Effect of Cannabinoid Receptors in Neuroinflamation

2017 · Gemma Navarro Brugal, Dasiel Borroto‐Escuela, et al. · Alzheimer s & Dementia

Works count: 2

Citation count:

H-index:

I10-index: